A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objective This study examines the potential role of candidate genes in moderating treatment effects of methylphenidate (MPH) in Attention-Deficit/Hyperactivity Disorder (ADHD). Method Eighty two subjects with ADHD aged 6 to 17 participated in a prospective, double-blind, placebo-controlled, multiple-dose, crossover titration trial of immediate release MPH three times daily. Subjects were assessed on a variety of parent and clinician ratings, and a laboratory math test. Data reduction based on principal components analysis identified statistically derived efficacy and side effect outcomes. Results ADHD symptom response was predicted by polymorphisms at the serotonin transporter (SLC6A4) intron 2 VNTR (p=.01), with a suggested trend for catechol-O-methyltransferase (COMT) (p=.04). Gene × dose interactions were noted on math test outcomes for the dopamine D4 receptor (DRD4) promoter (p=.008), DRD4 exon 3 VNTR (p=.006), and SLC6A4 promoter insertion/deletion polymorphism (5HTTLPR) (p=.02). Irritability was predicted by COMT (p=.02). Vegetative symptoms were predicted by 5HTTLPR (p=.003). No significance effects were noted for the dopamine transporter (SLC6A3) or synaptosomal-associated protein 25 (SNAP25). Conclusions This report confirms and expands previous studies suggesting that genes moderate ADHD treatment response. ADHD outcomes are not unitary, but reflect both behavioral and learning domains that are likely influenced by different genes. Future research should emphasize candidate gene and genome wide association studies in larger samples, symptom reduction as well as side effects outcomes, and responses over full therapeutic dose ranges to assess differences in both gene and gene × dose interactive effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
GREENHILL, L., KOLLINS, S., ABIKOFF, H., MCCRACKEN, J., RIDDLE, M., SWANSON, J., MCGOUGH, J., WIGAL, S., WIGAL, T., VITIELLO, B., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235077.32661.61 · Cited by 467 · cited 1×
“The subjects participated in a 4- or 5-week, double-blind, placebo-controlled, crossover titration trial of immediate-release methylphenidate modeled after other ADHD studies.(5,34,35) The subjects weighing less than 25 kg received 1 week each of 5 mg, 10 mg, 15 mg, or placebo t.”
Self-citationSprague, R. L., & Sleator, E. K. (1977) · Science · doi:10.1126/science.337493 · Cited by 441
Stimulant treatment over five years: adherence, effectiveness, and adverse effects
Charach, A., Ickowicz, A., & Schachar, R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200405000-00009 · Cited by 315
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers
GREENHILL, L. L., ABIKOFF, H. B., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., ELLIOTT, G., HECHTMAN, L., HINSHAW, S. P., HOZA, B., JENSEN, P. S., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199610000-00017 · Cited by 297
Safety and tolerability of methylphenidate in preschool children with ADHD
WIGAL, T., GREENHILL, L., CHUANG, S., McGOUGH, J., VITIELLO, B., SKROBALA, A., SWANSON, J., WIGAL, S., ABIKOFF, H., KOLLINS, S., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235082.63156.27 · Cited by 242
Ogdie, M. N., Macphie, I. L., Minassian, S. L., Yang, M., Fisher, S. E., Francks, C., Cantor, R. M., McCracken, J. T., McGough, J. J., Nelson, S. F., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375139 · Cited by 220
Self-citationMcCracken, J. T., Smalley, S. L., McGough, J. J., Crawford, L., Del'Homme, M., Cantor, R. M., Liu, A., & Nelson, S. F. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000770 · Cited by 189 · cited 2×
“The DRD4PROM 120/240-bp allele was genotyped using published methods and the following primers: F- 5¶-GTT GTC TGT CTT TTC TCA TTG TTT CCA TTG-3¶; R 5¶-GAA GAA GCAGGC ACCGTG AGC-3¶.44 TheDRD4VNTR was genotyped with the following modified primers: F- 5¶-CTA CCC TGC CCG CTC ATG-3¶; R- 5¶-CCG GTG ATC TTG GCA CGC-3¶ using…”
Pharmacogenetics of Methylphenidate Response in Preschoolers With ADHD
McGOUGH, J., McCRACKEN, J., SWANSON, J., RIDDLE, M., KOLLINS, S., GREENHILL, L., ABIKOFF, H., DAVIES, M., CHUANG, S., WIGAL, T., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235083.40285.08 · Cited by 126 · cited 6×
“Randomized, placebo-controlled studies are few, as are studies that assessed outcomes at multiple doses.(21,23,24) Only one explored gene dose interactions in addition to gene effects.”
InfluentialSelf-citation
Cited by
Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD
Myer, N. M., Boland, J. R., & Faraone, S. V. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.234 · Cited by 91
Kambeitz, J., Romanos, M., & Ettinger, U. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.9 · Cited by 64
Chantiluke, K., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht365 · Cited by 59
Angyal, N., Horvath, E. Z., Tarnok, Z., Richman, M. J., Bognar, E., Lakatos, K., Sasvari-Szekely, M., & Nemoda, Z. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.013 · Cited by 25
“At the MPH-response analysis responders had minimum 25% decrease of ADHD-RS total score after 2 months of treatment, and chi-square test compared 90 responders and 32 non-responders, whereas ANOVA was used to assess symptom improvement after the first month among the 122 ADHD patients.”
InfluentialStrengths and limitations of genetic models of ADHD
Gainetdinov, R. R. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0021-3 · Cited by 24
Metadata
- Authors
- McGough, J. J., McCracken, J. T., Loo, S. K., Manganiello, M., Leung, M. C., Tietjens, J. R., Trinh, T., Baweja, S., Suddath, R., Smalley, S. L., Hellemann, G., & Sugar, C. A.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 48
- Issue
- 12
- Pages
- 1155-1164
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W1981330536
- Cited by
- 80
- References
- 11
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder. https://app.cochat.ai/papers/10.1097/chi.0b013e3181bc72e3
- The paper
- McGough, J. J., McCracken, J. T., Loo, S. K., Manganiello, M., Leung, M. C., Tietjens, J. R., Trinh, T., Baweja, S., Suddath, R., Smalley, S. L., Hellemann, G., & Sugar, C. A. (2009). A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/chi.0b013e3181bc72e3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.